The novel vaccine delivery devices market is estimated to be worth USD 1.5 billion in 2030 Individuals1 month ago - Services - Union City - 65 views
The report features an extensive study of the currentlandscape and the likely future opportunities associated with novelvaccine delivery devices, over the next 10-12 years. Amongst otherelements, the report includes:
§ A detailed assessment of the overall novel vaccine deliverydevices market landscape, featuring an elaborate list of device developers engagedin the development of novel vaccine delivery devices.
§ A detailed competitiveness analysis of novel vaccinedelivery devices, taking into consideration the supplier power and key productspecifications.
§ An analysis evaluating the effectiveness of variousvaccines delivery devices in order to compare their respective strengths andcapabilities based on a variety of parameters.
§ A detailed list of marketed and pipeline vaccine candidatesthat are anticipated to be developed in combination with novel vaccine deliverydevices in the near future.
§ Elaborate profiles of prominent product developers engagedin the novel vaccine delivery devices domain (shortlisted on the basis ofthe number of pipeline products).
§ An analysis of the partnerships that have been establishedin this domain, in the recent past.
§ A discussion on important, industry-specific trends, keymarket drivers and challenges, under a comprehensive SWOT framework.
§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)
- Global Novel Vaccine Delivery Devices (By Value)
§ Type of Device
§ Electroporation-based Needle Free Injection Systems
§ Oral Delivery Systems
§ Nasal Delivery Systems
§ Jet Injectors
§ Microneedle Patches
§ Route of Administration
§ Type of Vaccines
§ Bivalent Oral Polio Vaccine
§ BCG Vaccine
§ DTP-HepB-Hib Vaccine
§ Pneumococcal Conjugate Vaccine
§ Influenza Vaccine
§ Measles Vaccine
§ Tetanus-Diphtheria Vaccine
§ Key Geographical Region
- North America
- Asia Pacific
- Rest of the World
Keycompanies covered in the -https://www.rootsanalysis.com/reports/280/request-sample.html
§ Becton Dickinson
§ Consort Medical
§ D’Antonio Consultants International
§ Enesi Pharma
§ Ichor Medical
§ Inovio Pharmaceuticals
§ Union Medico
For additional details, please visit
You may also be interested in the following titles:
About Roots Analysis
Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growing businessneeds, get in touch at [email protected]
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
Twitter - https://twitter.com/RootsAnalysis